HCW Biologics HCWB Q2 2026 earnings

FAQ

When did HCW Biologics report Q2 2026 earnings?

HCW Biologics (HCWB) reported Q2 2026 earnings on August 14, 2026 after market close.

What were HCW Biologics's Q2 2026 revenue and EPS?

HCW Biologics reported revenue of $135.6K and eps of $-11.58 for Q2 2026.

Did HCW Biologics beat estimates in Q2 2026?

Revenue beat the consensus estimate of $135.6K by -. EPS missed the consensus estimate of $-1.98 by $9.60.

How did HCW Biologics's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 1969.7% from $6.6K a year earlier and eps declined 70.5% from $-6.79.

Where can I find HCW Biologics's Q2 2026 SEC filings?

You can read the 8-K earnings release (0001493152-26-038240) and the 10-Q/A periodic report (0001493152-26-038246) directly on SEC EDGAR. The filing index links above go to sec.gov.